Evaluation of Safety, Tolerability, Pharmacokinetics, Drug-Drug and Food Interactions of Single and Multiple Doses of S-648414 in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 9, 2019

Primary Completion Date

September 22, 2020

Study Completion Date

September 29, 2020

Conditions

Healthy Volunteer

Interventions

DRUG

S-648414

Tablet for oral administration

DRUG

Placebo

Tablet for oral administration

DRUG

Midazolam

Solution for oral administration

DRUG

Dolutegravir

Tablet for oral administration

Trial Locations (2)

PPD Ph 1 Clinical Research Unit, Austin

P-One Clinic, Hachiōji